Discover one of our 28 local entrepreneurial communities »
Be the first to know as we launch in new countries and markets around the globe.
Interested in bringing MIT Technology Review to your local market?
Unsupported browser: Your browser does not meet modern web standards. See how it scores »
A hedge fund manager aims to solve the funding problems facing early-stage biomedical research.
New drugs in clinical trials for muscle-wasting diseases could become the next big thing for athletes.
A promising device uses electric fields to destroy cancer cells in the brain.
A personalized therapy targets the molecular mechanism behind a specific kind of tumor.
Scientists have uncovered genetic targets that could increase lung-cancer cells’ sensitivity.
A new microfluidics device gives results in 15 minutes.
Converting genetic activity into music may be a way to monitor health.
Researchers hope that curcumin encapsulated in nanospheres will spice up clinical trials for Alzheimer’s, cystic fibrosis, and cancer.
One startup, H3 Biomedicines, uses genome data to design drugs aimed at small groups of patients.